Vocal Biomarker Market Booms as Non-Invasive Diagnostic Tool for Parkinson’s Disease

The global vocal biomarker market stands at US$ 2.3 billion in 2023 and is forecasted to surpass a valuation of US$ 9 billion by 2033-end. Over the next ten years, global demand for vocal biomarkers is estimated to surge at a CAGR of 14.7%. The vocal biomarker market refers to the use of voice analysis technology to detect and monitor changes in an individual’s voice that may indicate the presence of a particular medical condition or emotional state. This technology involves analyzing the acoustic properties of an individual’s voice, such as pitch, tone, and volume, and comparing them to a database of known patterns and markers associated with certain health conditions

The market for vocal biomarkers is expected to grow significantly in the coming years, driven by increasing demand for non-invasive and cost-effective diagnostic tools, as well as advancements in artificial intelligence and machine learning technologies that enable more accurate and reliable analysis of voice data. The technology has a wide range of potential applications, including the diagnosis and monitoring of conditions such as depression, anxiety, Parkinson’s disease, and Alzheimer’s disease.

Download Free Sample Copy of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=719

Key Takeaways:

  • By indication, the cardiovascular disorders segment is projected to hold lion’s share in the vocal biomarker market by 2033.
  • Neurological disorders are expected to remain at the second position in terms of share, followed by cardiovascular disorders.
  • The USA vocal biomarker market is set to showcase an astonishing share with increasing prevalence of Parkinson’s disease.
  • In Asia Pacific, Japan is estimated to surge at a fast pace throughout the forecast period.
  • Korea vocal biomarker market is expected to create new opportunities in the next ten years amid high investments in healthcare infrastructure.

Regional Analysis

The vocal biomarker market is expected to witness significant growth globally, with the North American region leading the market share in terms of revenue due to the presence of major companies and high adoption of advanced healthcare technologies. The Asia-Pacific region is expected to witness the highest growth rate in the coming years due to the increasing healthcare expenditure, a large patient pool, and growing awareness about early disease detection. Furthermore, increasing government initiatives, investments in healthcare infrastructure, and the growing focus on personalized medicine are expected to boost the market growth in this region.

Europe is also a significant market for vocal biomarkers, with a growing focus on research and development of new applications of vocal biomarkers. The region has a well-established healthcare infrastructure, and increasing investments in the development of advanced diagnostic tools are expected to propel market growth in this region. The Rest of the World region, including regions such as Latin America and the Middle East, is also expected to witness moderate growth in the coming years, with increasing investments in healthcare infrastructure and growing awareness about the benefits of non-invasive diagnostic tools. Overall, the global vocal biomarker market is expected to witness significant growth in the coming years, driven by advancements in AI and machine learning technologies and the increasing demand for non-invasive and cost-effective diagnostic tools.

Get Customization on this Report for Specific Research Solutions – https://www.factmr.com/connectus/sample?flag=RC&rep_id=719

Competitive Landscape

Top vocal biomarker suppliers are concentrating on creating and releasing new products that aid them in maximising the usage of voice biomarkers for various use cases.

  • In October 2021,A voice sample is used by Sonde Health’s mental health monitoring technology to assess a person’s mental health. As an application programming interface (API), the Sonde Mental Fitness technology was accessible to wellness service providers, healthcare systems, and employers.

Key Companies Profiled

  • Boston Technology Corporation
  • EVOCAL Health
  • Audio Profiling
  • Cogito Corporation
  • Kintsugi
  • Sharecare Inc.
  • Microtest Health
  • Sonde Health
  • Beyond Verbal
  • IBM Corporation

Key Segments of Vocal Biomarker Industry Research

  • By Technique :
    • Frequency
    • Amplitude
    • Error Rate
    • Vocal Rise or Fall Time
    • Phonation Time
    • Voice Tremor
    • Pitch
    • Others
  • By Indication :
    • Psychiatric Disorders
    • Respiratory Disorders
    • Cardiovascular Disorders
    • Traumatic Brain Injury (TBI)
    • Neurological Disorders
    • Other Disorders
  • By End User :
    • Hospitals & Clinics
    • Contract Research Organizations (CROs)
    • Academic & Research Centers
    • Other End Users

For in-depth competitive analysis, Buy Now – https://www.factmr.com/checkout/719

Key Questions Covered

  1. What are vocal biomarkers, and how do they work?
  2. What are the major applications of vocal biomarkers in healthcare?
  3. What are the drivers and restraints of the vocal biomarker market?
  4. Who are the key players operating in the vocal biomarker market, and what are their market strategies?


US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Original Source of the original story >> Vocal Biomarker Market Booms as Non-Invasive Diagnostic Tool for Parkinson’s Disease